Ja. Burger et al., Local and systemic effects after adenoviral transfer of the murine granulocyte-macrophage colony-stimulating factor gene into mice, BR J HAEM, 108(3), 2000, pp. 641-652
Vectors encoding immunostimulatory genes are under investigation for their
use as adjuvants for immunotherapy. Granulocyte-macrophage colony-stimulati
ng factor (GM-CSF) is a prominent candidate gene for this approach because
this cytokine can prime immune responses to 'self' tumour or other weak ant
igens. Prior studies suggested that GM-CSF induces accumulation and differe
ntiation of antigen-presenting cells, particularly dendritic cells that can
initiate immunity. To evaluate this model in vivo, we performed i.m. and i
.p. injections of an adenovirus vector encoding murine GM-CSF (Ad-mGM-CSF)
and evaluated local and systemic effects. After intramuscular injection, lo
cal changes were characterized by the accumulation of myeloid cells, a subs
equent infiltration of lymphocytes and then myonecrosis. Intraperitoneal in
jection also induced an accumulation of myeloid cells, an increase in CD3-p
ositive T and a decrease in B220-positive B lymphocytes. Expression of the
dendritic cell marker CD11c on 48 +/- 9% of the peritoneal cells (n = 6) al
ong with high levels of surface MHC class II, a characteristic morphology,
and endocytosis of FITC-dextran suggested in vivo differentiation of dendri
tic cells after i.p. injection of Ad-mGM-CSF. Systemic effects were observe
d after i.m. and i.p. injection of Ad-mGM-CSF. All mice developed hepatospl
enomegaly resulting from extramedullary haematopoiesis. These changes were
specific to GM-CSF as they were not seen in mice injected with an adenoviru
s vector without a transgene. Our observations indicate that adenoviral tra
nsfer of GM-CSF is a powerful tool for inducing local and systemic expansio
n of haematopoietic cells. The local expansion of myeloid cells displaying
signs of dendritic cell differentiation, as characterized for the peritonea
l cell compartment, can explain the potency of GM-CSF when used as an adjuv
ant in genetic immunotherapy.